Medical imaging reagents are chemicals used to picture structures or organs, thus supporting physicians to better analyze and detect diseases. Hence, these composites are broadly applicable in detection and imaging technologies in medical and healthcare industry and many life science-related fields such as biotechnology, medicine, and pharmaceutical research. The primarily used imaging technologies are computed tomography, magnetic resonance imaging (MRI), X-ray and others. Imaging technologies examine the morphology and anatomy of human body; but these methods cannot identify any changes at the molecular level.

Market Dynamics

The global medical imaging reagents market is driven by rising cases of chronic diseases such as cancer and cardiovascular diseases, increase in technological advancements, and high unmet medical and diagnostic imaging procedure needs. In addition, rapidly growing geriatric population, increase in expenditure on healthcare, and growth in demand for effective procedures and safe medication are expected to fuel the market growth. However, lack of reagent suppliers and strict government regulations restrict this growth in developing regions.

Medical imaging reagents are used to visualize and detect any cellular change using different imaging equipment such as Positron emission tomography (PET) and MRI. Based on application, the market is categorized into diagnostics, drug discovery & development, and R&D. The diagnostics segment was the highest contributor towards the global market due to the rise in number of patients suffering from chronic disorders such as cancer, neurological diseases, and cardiovascular diseases. Diagnostic imaging refers to the use of technologies that help to diagnose various pathologies by visualizing different components inside the body. It is increasingly becoming an important part of diagnostic portfolio for healthcare professionals due to the unparalleled results that the imaging techniques can provide into the human body. Various imaging technologies such as MRI, CT, and PET are becoming part of the routine procedures performed in hospitals, worldwide. Imaging reagents assist healthcare practitioners to visualize abnormalities on a diagnostic image. However, the drug discovery & development segment is estimated to grow at the highest CAGR during the forecast period, owing to the growing demand for novel drugs.

Report coverage

The market research study on “Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents, Nuclear Reagents; Technology: Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots; Application: Diagnostics, Drug Discovery & Development, R&D) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2017 - 2023” offers a detailed study on the medical imaging reagents market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact analysis are provided. Information about Porter's five forces analysis is also mentioned. The report provides insights on global medical imaging reagents market, its class, technology, application, and major geographic regions. Secondly, the report covers global medical imaging reagents market size, and the segment markets by class, technology, application and geography along with the information on companies operating in the market. The medical imaging reagents market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, and LAMEA followed by major countries. For each region, the market sizes for different segments has been covered under the scope of report. Some of the major players profiled in the report include Covalon Technologies Ltd., Shimadzu Corporation, Lantheus Medical Imaging, Inc., Bayer Healthcare AG, Bracco Imaging SpA, Siemens Healthcare, Thermo Fisher Scientific, Inc., Merck, Philips Healthcare, GE Healthcare and others.

The global medical imaging reagents market is segmented as below:

Market Segmentation

• Contrast Reagents
• Optical Reagents
• Nuclear Reagents

• Nanoparticles
• Fluorescent Dyes & Probes
• Radiopharmaceuticals
• Fluorescent Proteins
• Quantum Dots 

• Diagnostics
• Drug Discovery & Development
• R&D

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Republic of South Africa
  • Saudi Arabia
  • Rest of LAMEA